New Guidelines For Management Of Diabetic Foot
New Guidelines for Management of Diabetic Foot Authors: News Author: Lisa Nainggolan; CME Author: Charles P. Vega, MD, FAAFP Physicians - maximum of 0.25 AMA PRA Category 1 Credit(s) Family Physicians - maximum of 0.25 AAFP Prescribed credit(s) ABIM Diplomates - maximum of 0.25 ABIM MOC points Nurses - 0.25 ANCC Contact Hour(s) (0 contact hours are in the area of pharmacology) This article is intended for primary care physicians, endocrinologists, orthopedists, podiatrists, nurses, and other clinicians who care for patients with diabetes. The goal of this activity is to provide medical news to primary care clinicians and other healthcare professionals in order to enhance patient care. Upon completion of this activity, participants will be able to: Assess screening intervals and interventions for patients with diabetes based on their risks for foot ulceration and amputation Distinguish best treatment practices for diabetic foot ulcers and Charcot foot As an organization accredited by the ACCME, Medscape, LLC, requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest. Medscape, LLC, encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content. Disclosure: Lisa Nainggolan has disclosed no relevant financial relationships. Disclosure: Amy Bernard, MS, BSN, RN-BC, has disclosed no relevant financial relationsh Continue reading >>
International Diabetes Federation - Idf Clinical Practice Recommendations On The Diabetic Foot
IDF Clinical Practice Recommendations on the Diabetic Foot Long-term complications of diabetes develop gradually. The longer you have diabetes and the less controlled your blood sugar the higher the risk of complications. With the growing number of people living with diabetes worldwide, healthcare professionals are encouraged to pay attention to the major complications of diabetes in their daily practice. It is therefore IDFs vision is to develop a series clinical practice recommendations for health care professionals on specific topics, with the aim of creating clinical guidelines in an easily digestible and user-friendly format, adaptable to any country, region or health setting. Diabetic foot disease, mainly due to neuropathy, peripheral arterial disease, and/or infection, often leads to ulceration and possible subsequent limb amputation. It is one of the most costly complications of diabetes, and can result in an important economic, social, and public health burden; especially in low-income communities, if there is neither an appropriate educational programme, nor adequate and suitable footwear. The IDF Clinical Practice Recommendations on the Diabetic Foot are simplified, easy to digest guidelines to prioritize health care practitioner's early intervention of the diabetic foot with a sense of urgency through education. The main aims of the guidelines are to promote early detection and intervention; provide the criteria for time- adequate referral to a second or third level centers and serve as a tool to educate people with diabetes about the importance of prevention of this pathology. They are also designed to provide clinicians with practice recommendations based on published evidence, which have been validated through reviews and field-testing by experienced dia Continue reading >>
International Diabetes Federation
Advancing diabetes care, prevention and a cure worldwide Since 1950 Associated with the United Nations Department of Public Information In official relations with the World Health Organization and Pan-American Health Organization IDF championed the UN Resolution on Diabetes (UN Resolution 61/225) What is the IDF? NGO with HQ in Brussels 203 national diabetes associations, 162 countries, over 2 million members Voice of diabetes globally (250 million) In official relations with WHO, UN (DPI) IDF championed the UN Resolution on Diabetes (UN Resolution 61/225) A Federation of 203 national diabetes associations, 162 countries, over 2 million members Voice of diabetes globally (250 million) International Diabetes Federation Since 1950 Associated with the United Nations Department of Public Information In official relations with the World Health Organization and Pan-American Health Organization IDF championed the UN Resolution on Diabetes (UN Resolution 61/225) IDF Programs IDF Clinical Guidelines IDF Atlas (single congruent data source) IDF Centres of Diabetes Education IDF Life for a Child IDF World Diabetes Congresses UN World Diabetes Day Empower, Educate, Energise (Understand diabetes and take control) IDF Programs IDF Programs IDF Clinical Guidelines IDF Atlas (single congruent data source) IDF Centres of Diabetes Education IDF Life for a Child IDF World Diabetes Congresses UN World Diabetes Day Empower, Educate, Energise (Understand diabetes and take control) It was obvious how divided the diabetes organizations were and many were head to head competitors. We created the concept of a “diabetes world†working under the banner of a blue circle representing an Unite for diabetes movement. We have used this slide a lot recently to demonstrate the growing recogniti Continue reading >>
Guidelines
There is now extensive evidence on the optimal management of diabetes, offering the opportunity of improving the immediate and long-term quality of life of those living with the condition. Unfortunately such optimal management is not reaching many, perhaps the majority, of the people who could benefit. Reasons include the size and complexity of the evidence-base, and the complexity of diabetes care itself. One result is a lack of proven cost-effective resources for diabetes care. Another result is diversity of standards of clinical practice. Guidelines are part of the process which seeks to address those problems. IDF has produced a series of guidelines on different aspects of diabetes management, prevention and care. IDF Clinical Practice Recommendations for Managing Type 2 Diabetes in Primary Care The new IDF Clinical Practice Recommendations for managing Type 2 Diabetes in Primary Care seek to summarise current evidence around optimal management of people with type 2 diabetes. It is intended to be a decision support tool for general practitioners, hospital based clinicians and other primary health care clinicians working in diabetes. Continue reading >>
International Diabetes Federation
The International Diabetes Federation (IDF) is a worldwide alliance of over 230 national diabetes associations in more than 160 countries, who have come together to enhance the lives of people with diabetes everywhere. The Federation is committed to raising global awareness of diabetes, promoting appropriate diabetes care and prevention, and encouraging activities towards finding a cure for the different types of diabetes. The Federation has been leading the global diabetes community since 1950. It is headquartered in Brussels, Belgium. According to the latest IDF figures,[1] there are currently 415 million people living with diabetes and the total is expected to rise to 640 million by 2040. Some 75% of people with diabetes live in low- and middle-income countries and almost half of people living with diabetes are undiagnosed. Organization[edit] IDF is divided into seven regions,[2] with the aim of strengthening the work of national diabetes associations and enhancing the collaboration between them. IDF’s national diabetes associations are divided into the following regions: Africa (AFR),Europe (EUR),Middle East and North Africa (MENA), North America and Caribbean (NAC), South and Central America (SACA), South East Asia (SEA) and Western Pacific (WP). IDF’s working bodies bring together the most important stakeholders from the global diabetes community in a collaborative effort to set common goals and co-ordinate activities towards the attainment of these goals. These stakeholders include: people with diabetes and their families; professionals involved in diabetes healthcare and related fields; diabetes representative organizations, and partners from commercial organizations with concerns which align with the mission of the Federation. IDF is associated with the Dep Continue reading >>
International Diabetes Federation Guideline For Management Of Postmeal Glucose: Areview Of Recommendations.
1. Diabet Med. 2008 Oct;25(10):1151-6. doi: 10.1111/j.1464-5491.2008.02565.x. International Diabetes Federation guideline for management of postmeal glucose: areview of recommendations. (1)Clinical Science Research Institute, Warwick Medical School, Coventry, UK. [email protected] Diabetes is a significant and growing concern, with over 246 million peoplearound the world living with the disease and another 308 million with impairedglucose tolerance. Depending on the resources of different nations, intervention has generally focused on optimizing overall glycaemic control as assessed byglycated haemoglobin (HbA(1c)) and fasting plasma glucose (FPG) values.Nevertheless, increasing evidence supports the importance of controlling allthree members of the glucose triad, namely HbA(1c), FPG and postmeal glucose(PMG) in order to improve outcome in diabetes. As part of its global mission topromote diabetes care and prevention and to find a cure, the InternationalDiabetes Federation (IDF) recently developed a guideline that reviews evidence todate on PMG and the development of diabetic complications. Based on an extensive database search of the literature, and guided by a Steering and DevelopmentCommittee including experts from around the world, the IDF Guideline forManagement of Postmeal Glucose offers recommendations for appropriate clinicalmanagement of PMG. These recommendations are intended to help clinicians andorganizations in developing strategies for effective management of PMG inindividuals with Type 1 and Type 2 diabetes. The following review highlights the recommendations of the guideline, the supporting evidence provided and the major conclusions drawn. The full guideline is available for download at Continue reading >>
Perio-diabetes Workshop Organized Jointly By The European Federation Of Periodontology (efp) And The International Diabetes Federation (idf) In Partnership With Sunstar
Perio-Diabetes Workshop organized jointly by the European Federation of Periodontology (EFP) and the International Diabetes Federation (IDF) in partnership with Sunstar An unprecedented international summit where fifteen leading global figures assessed the scientific evidence on the links between periodontal diseases and diabetes, and developed guidelines for physicians, dentists, and patients Experts from the fields of gum health and diabetes met in Madrid on February 19 and 20, 2017 at the SEPA Gum Health Center for the Perio-Diabetes Workshop, a pioneering international summit which explored the latest evidence on the links between periodontal diseases and diabetes. The workshop reached a new scientific consensus on how these widespread chronic conditions reinforce each other and produced recommendations on how dentists and physicians can work more effectively together to help prevent and treat them. Periodontitis patients have a higher chance of developing pre-diabetes and type-2 diabetes. While there is no data to support a causal relationship between the periodontal microbiome, the microorganisms involved in gum disease, and the presence of diabetes, recent studies do show an association between altered glucose metabolism in pre-diabetes and diabetes and changes in the periodontal microbiome. There is a moderate level of evidence that certain biological mechanisms mediate the effect of periodontitis on the control of diabetes. There is evidence that improving the control of diabetes results in improvements to periodontal status and that improving periodontal health has benefits in improving metabolic control and/or the complications of diabetes. Guidelines drawn up by the workshop include providing oral-health education to all patients with diabetes and informing Continue reading >>
Guidelines
There is now extensive evidence on the optimal management of diabetes, offering the opportunity of improving the immediate and long-term quality of life of those living with the condition. Unfortunately such optimal management is not reaching many, perhaps the majority, of the people who could benefit. Reasons include the size and complexity of the evidence-base, and the complexity of diabetes care itself. One result is a lack of proven cost-effective resources for diabetes care. Another result is diversity of standards of clinical practice. Guidelines are part of the process which seeks to address those problems. IDF has produced a series of guidelines on different aspects of diabetes management, prevention and care. The new IDF Clinical Practice Recommendations for managing Type 2 Diabetes in Primary Care seek to summarise current evidence around optimal management of people with type 2 diabetes. It is intended to be a decision support tool for general practitioners, hospital based clinicians and other primary health care clinicians working in diabetes. Pocket chart in the format of a Z-card with information for health professionals to identify, assess and treat diabetic foot patients earlier in the "window of presentation" between when neuropathy is diagnosed and prior to developing an ulcer. The content is derived from the IDF Clinical Practice Recommendations on the Diabetic Foot 2017. Available to download and to order in print format. The IDF Clinical Practice Recommendations on the Diabetic Foot are simplified, easy to digest guidelines to prioritize health care practitioner's early intervention of the diabetic foot with a sense of urgency through education. The main aims of the guidelines are to promote early detection and intervention; provide the criteria for Continue reading >>
How To Cite The Atlas
In order to correctly cite the IDF Diabetes Atlas 8th edition, please use either of the following: PRINT VERSION International Diabetes Federation. IDF Diabetes Atlas, 8th edn. Brussels, Belgium: International Diabetes Federation, 2017. ONLINE VERSION International Diabetes Federation. IDF Diabetes Atlas, 8th edn. Brussels, Belgium: International Diabetes Federation, 2017. Continue reading >>
. Global Guideline For Type 2 Diabetes
Background: The prevalence of diabetes has reached epidemic proportions both in the United States and worldwide. A recent World Health Organization (WHO) report has estimated the prevalence has quadrupled in just three decades and is directly responsible for the deaths of 1.5 million people worldwide. More than 80% of these deaths occur in low and middle income countries. The forecasted urban population in developing nations is expected to double by the year 2030, compared to the year 2000.Methods: We utilized a limited teaching dataset from the Framingham Heart Study to examine the relationship between blood glucose levels and mortality using a Multivariate Cox proportional hazards model, adjusting for age, gender, body mass index and blood pressure. We divided glucose according to four categories, with normal reflecting conventional intensive control, high-normal reflecting a higher glucose level and moderate and severe elevations for further comparison of relative mortality.Results: 3,270 subjects were followed for 20 years, of which 316 fell into a high normal blood glucose category and 2,885 subjects had a normal blood glucose. The relative risk of death in the high normal random blood glucose (RBG) group was 1.22 times that of those with a random normal blood glucose (95% CI: 1.021.45; pvalue = 0.030).Discussion: A high normal random glucose level with limited covariates may prognosticate a greater risk of allcause morbidity and mortality compared to low normal glucose levels. These findings may help to provide estimates of risk in low and middle-income countries, where there is limited access to healthcare and basic lab testing such as HgbA1c. Background and Aim. Diabetes mellitus is a chronic disease that has a great impact on patients and society. Metformin mo Continue reading >>
Guidelines
There is now extensive evidence on the optimal management of diabetes, offering the opportunity of improving the immediate and long-term quality of life of those living with the condition. Unfortunately such optimal management is not reaching many, perhaps the majority, of the people who could benefit. Reasons include the size and complexity of the evidence-base, and the complexity of diabetes care itself. One result is a lack of proven cost-effective resources for diabetes care. Another result is diversity of standards of clinical practice. Guidelines are part of the process which seeks to address those problems. IDF has produced a series of guidelines on different aspects of diabetes management, prevention and care. Global Guideline for Type 2 Diabetes In 2005 the first IDF Global Guideline for type 2 diabetes was developed. This presented a unique challenge as we tried to develop a guideline that is sensitive to resource and cost-effectiveness issues. Many national guidelines address one group of people with diabetes in the context of one health-care system, with one level of national and health-care resources. This is not true in the global context where, although every health-care system seems to be short of resources, the funding and expertise available for health-care vary widely between countries and even between localities. This guideline represents an update of the first guideline and extends the evidence base by including new studies and treatments which have emerged since the original guideline was produced in 2005. Download Continue reading >>
Iwgdf | The International Working Group On The Diabetic Foot
It is estimated that in 2013 approximately 382 million people have diabetes 8.3% of the worlds population. Around 80% of these people live in developing countries. By 2030, the global estimate is expected to rise to over 552 million 9.9 % of the adult population. Every 20 seconds a lower limb is lost to diabetes somewhere in the world. The International Working Group on the Diabetic Foot (IWGDF) was founded in 1996. It is an non-profit and independent foundation. The aim of the IWGDF is to create awareness of the disease and to improve the management and prevention of the diabetic foot. This website provides information on the global activities and programmes of the IWGDF. Since 1999 the IWGDF produces quadrennial Practical, Specific and Consensus guidelines on the management and prevention of the diabetic foot. The complete 2011 IWGDF guidelines are available on the site, including references, a picture gallery and some education videos. Besides news items on the diabetic foot, foot notes, an agenda on future foot meetings and an overview of the IWGDF representatives throughout the world can be found on the website. Continue reading >>
Adea | International And National Guidelines
The Outcomes and Indicators for Diabetes Education A National Consensus Position a framework of nationally agreed goals, outcomes and indicators for diabetes education. It provides a benchmark and a policy platform for refining and evaluating the consistency, quality and effectiveness of diabetes education which can be applied nationally and/or at a regional or local service. To learn more, please read or download your copy by clicking here . The Evidenced-Based Guidelines for Patient Education in Type 2 Diabetes a comprehensive guideline for the practice of diabetes self management education. It is available from the websites of Diabetes Australia (DA) and the National Health and Medical Research Council (NHMRC). Type 2 diabetes aset of evidence-based guidelines are available for the prevention, diagnosis and management of type 2 diabetes. These comprehensive guidelines were first published in 2001, updated in 2009 and include: Prevention and detection of macro vascular disease in Type Detection and prevention of foot problems Diagnosis, prevention and management of chronic kidney disease To view, please visit the website of DA and the NHMRC . Type 1 diabetes guidelines developed bu the Australasia Paediatric Endocrine Group (APEG) relevant to all aspects of diagnosis and clinical management of type 1 diabetes in children of all ages, including adolescents up to the point of transition to adult care. To view these, please visit the website of the APEG or the NHMRC . Gestational diabetes mellitus consensus guidelines for the management of gestational diabetes mellitus are available from the website of the Australasian Diabetes in Pregnancy Society (ADIPS). Pregnancy in diabetes consensus guidelines for the management of type 1 diabetes and type 2 in pregnancy are avail Continue reading >>
Diabetes And Ramadan: Practical Guidelines - Sciencedirect
Diabetes and Ramadan: Practical guidelines Author links open overlay panel MohamedHassaneina Ramadan fasting is one of the five pillars of Islam and is compulsory for all healthy Muslims from puberty onwards. Exemptions exist for people with serious medical conditions, including many with diabetes, but a large number will participate, often against medical advice. Ensuring the optimal care of these patients during Ramadan is crucial. The International Diabetes Federation (IDF) and Diabetes and Ramadan (DAR) International Alliance have come together to deliver comprehensive guidelines on this subject. The key areas covered include epidemiology, the physiology of fasting, risk stratification, nutrition advice and medication adjustment. The IDF-DAR Practical Guidelines should enhance knowledge surrounding the issue of diabetes and Ramadan fasting, thereby empowering healthcare professionals to give the most up-to-date advice and the best possible support to their patients during Ramadan. Continue reading >>
Idf Publicizes Guidelines For Diabetic Foot For Gps, Other Healthcare Providers
The new 70-page IDF document Clinical Practice Recommendations on the Diabetic Foot 2017: A guide for healthcare professionals divides topics, by increasing severity, into diabetic peripheral neuropathy, peripheral arterial disease, ulcers, diabetic-foot infection, and Charcot neuro-osteoarthropathy (Charcot foot). It is designed with the goal of having GPs intervene at risk category 1 or 2, to help them identify, assess, and treat diabetic-foot patients earlier in the "window of presentation" between when neuropathy is diagnosed and prior to an ulcer developing, Dr Jude noted. The old way of simply "looking for ulcers" means patients are referred far too late, delegates heard. Too Complex for GPs? There's a Pocket Guide, Too However, the chair of the session, Dr William Jeffcoate of Nottingham University Hospitals Trust, United Kingdom, said he felt this 70-page document "is too complicated for primary-care or any other healthcare professional not working in diabetic-foot disease." The authors were keen to stress, however, that they have also produced a pocket chart . This Z card consists of just 2 pages and can be printed off, or a hard copy ordered from the IDF website for just 2, Dr Jude explained. This short document enables doctors to put patients into one of four risk categories based on the results of assessment and then advises them on future decisions depending on the risk category assigned. Nevertheless, Prof Wens observed there remains much work to do looking for relevant clinical trials he found there is little research into the feasibility and implementation of diabetic-foot guidelines in primary care, despite the fact that at least 10 such guidelines exist around the world, including the ADA ones and these latest from IDF. And there are still sections mi Continue reading >>
